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Abstract  
Objectives. Provoked vestibulodynia (PVD) is suspected to be the most frequent cause of vulvodynia in 
premenopausal women. Based on the onset of PVD relative to the start of sexual experience, PVD can 
be divided into primary (PVD1) and secondary PVD (PVD2). Studies comparing these PVD subgroups are 
inconclusive as to whether differences exist in sexual and psychosocial functioning.  
Aim. To compare the pain, sexual and psychosocial functioning of a large clinical and community-based 
sample of premenopausal women with PVD1 and PVD2. 
Methods: A total of 269 women (n= 94 PVD1; n= 175 PVD2) completed measures on 
sociodemographics, pain, sexual and psychosocial functioning. 
Main Outcome Measures. Dependent variables were the 0-10 pain numerical rating scale, McGill-
Melzack Pain Questionnaire, Female Sexual Function Index, Global Measure of Sexual Satisfaction, Beck 
Depression Inventory-II, Painful Intercourse Self-Efficacy Scale, Pain Catastrophizing Scale, State-Trait 
Anxiety Inventory Trait Subscale,  Ambivalence over Emotional Expression Questionnaire, Hurlbert Index 
of Sexual Assertiveness, Experiences in Close Relationships Scale-Revised , and Dyadic Adjustment Scale-
Revised. 
Results: At first sexual relationship, women with PVD2 were significantly younger than women with 
PVD1 (P<.01). The average relationship duration was significantly longer in women with PVD2 compared 
to women with PVD1 (P<.01). Although women with PVD1 described a significantly longer duration of 
pain compared to women with PVD2 (P<.01), no significant subtype differences were found in pain 
intensity during intercourse. When controlling for the above sociodemographics, no significant 
differences were found in sexual, psychological and relational functioning between the PVD subgroups. 
Nevertheless, on average, both groups were in the clinical range of sexual dysfunction and reported 
impaired psychological functioning. 
Conclusions: The findings show that there are no significant differences in the sexual and psychosocial 
profiles of women with PVD1 and PVD2. Results suggest that similar psychosocial and sex therapy 
interventions should be offered to both subgroups of PVD. 
 
Introduction 
Vulvodynia, or chronic unexplained vulvar pain, is a major health concern for women of all ages. With a 
prevalence of 8% in the general population, vulvodynia affects women across the lifespan and across 
ethnic and socioeconomic groups [1]. Provoked vestibulodynia (PVD) – an acute recurrent pain localized 
within the vulvar vestibule and experienced primarily during intercourse – is suspected to be the most 
frequent cause of vulvodynia in premenopausal women [2]. Based on the onset of PVD relative to the 
start of sexual experience, PVD can be divided into primary (PVD1) and secondary PVD (PVD2). Women 
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with PVD1 report pain from early attempts at penetration (including tampon insertion, sexual activity, 
etc.), whereas women with PVD2 are characterized by recalling a period of pain-free intercourse. The 
subtypes of primary (lifelong) and secondary (acquired) vestibulodynia are widely used in many 
classification systems, such as the DSM-5 classification for genito-pelvic pain / penetration disorder 
[3] and the ISSVD classification of vulvodynia [4]. Despite evidence of biomedical differences between 
both PVD subgroups [5-18], research comparing sociodemographics, pain, sexual and psychosocial 
functioning in both entities has generated conflicting data [6, 18, 19]. The discrepancies in findings could 
be explained by the fact that most studies have been limited by small, clinical samples and have focused 
on a limited number of sexual and psychosocial variables.  
Several authors hypothesize that different etiological pathways may lead to PVD1 and PVD2 [6-14]. 
Studies have suggested a different genetic profile in women with PVD1 and PVD2 [9-12]. Goetsch et al. 
(1991) noted that women with PVD1 tended to have strong family histories of dyspareunia [9]. More 
recently, it has been shown that women with PVD1 were significantly more likely to display a Mannose-
binding lectin (MBL) gene polymorphism, MBL*B compared to women with PVD2 [12] and that women 
with PVD1 may have developed their disorder because of a congenital neuronal hyperplasia in the 
urogenitally derived tissue [10]. Indeed, recent histologic studies showed significant neural hypertrophy 
and hyperplasia in PVD1 compared to PVD2 [7, 8]. These differences in nerve fibers may account for a 
difference in sensitivity to pain between both PVD subtypes. Focusing on pain perception, studies have 
shown that compared to women with PVD2, women with PVD1 reported a higher sensitivity to thermal 
stimuli on the forearm and vestibule [18], and higher pain ratings for suprathreshold heat stimuli [6]. In 
addition, there is some evidence that women with PVD2 may have a better treatment outcome than 
women with PVD1. A study on the multidisciplinary treatment for PVD showed that women with PVD2 
were more likely to have major improvement compared to women with PVD1 [5]. Furthermore, 
previous research suggested that women with PVD2 respond better to vestibulectomy than women 
with PVD1 [15, 16, 20]. Published findings concerning sociodemographics, pain, sexual and psychosocial 
aspects of these conditions have not necessarily mirrored the differences found in these biomedical 
studies. 
 
To date, inconsistencies have been reported regarding the age of women with PVD1 and PVD2, with 
some studies showing that women with PVD1 were more likely to be younger than women with PVD2 
[7, 11, 14], whereas other studies did not find a significant age difference between the two subgroups 
[6, 18, 19]. Furthermore, in terms of sociodemographic characteristics, previous research showed no 
significant PVD subtype differences on level of education [6, 14, 18, 19], income [18, 19] and length of 
the present romantic relationship [19]. 
 
Although no significant differences in duration of pain symptoms between both PVD subtypes had been 
reported [8, 11, 18], two studies recently showed that women with PVD1 experienced pain during 
penetration for a significantly longer time than women with PVD2 [7, 19]. Further, in contrast to 
previous studies [5, 19], Brotto et al. (2014) also found that women with PVD2 rated their overall 
vestibular pain significantly higher than women with PVD1 [19]. The larger sample sizes in recent studies 
may explain some of these discrepancies.  
 
Using the Female Sexual Functioning Index (FSFI) in a sample of 26 women diagnosed with PVD, a cross-
sectional study showed that women with PVD1 and PVD2 did not differ on any measures of sexual 
response [18]. In contrast, a recent study of 132 women consulting a tertiary center for the treatment of 
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their vulvo-vagional pain, showed that women with PVD2 reported lower sexual functioning compared 
to women with PVD1 [19]. Specifically, women with PVD2 reported significantly lower levels of desire, 
arousal, lubrication, orgasm, satisfaction and overall sexual function. Given that in this cross-sectional 
study, pain severity during intercourse was significantly - although weakly - correlated with low desire 
and low lubrication scores on the FSFI, the authors stated that the higher pain intensity in women with 
PVD2 may have contributed to their lower levels of sexual functioning [19].  
 
In terms of psychological and relational functioning, research published to date suggests that women 
with PVD1 reported more symptoms of trait anxiety [6] and lower levels of emotional and social 
functioning [18] than women with PVD2. Furthermore, a small study of 50 women showed that 
compared to women with PVD2, women with PVD1 were more avoidant of sexuality [21]. A cross-
sectional study evaluating a limited number of psychological variables showed that women with PVD1 
reported significantly more role limitations due to emotional functioning, and increased levels of self-
consciousness about their bodies during sex compared to women with PVD2 [18]. In contrast, findings 
from a large clinical study did not indicate significant differences in depression, anxiety, pain self-efficacy 
and catastrophizing, or relationship adjustment between the two subgroups [19].   
 
Previous research in individuals with chronically painful conditions has shown that more interpersonal 
variables may influence their sexual and psychosocial functioning as well. Ambivalence over emotional 
expression, defined as the extent to which a person is comfortable with the way he or she expresses 
emotions [22], has been shown to predict more pain, disability and psychological distress in patients 
with chronic low back pain, gastrointestinal cancer and PVD [23-25]. Furthermore, a recent study 
involving 101 couples in which the women presented with PVD showed that both anxious (anxiety about 
rejection) and avoidant (avoidance of intimacy) attachment styles were associated with women’s lower 
sexual satisfaction [26]. Attachment avoidance was also associated with women’s lower sexual function 
[26]. Interestingly, women’s sexual assertiveness was found to be a significant mediator of the 
relationship between their attachment styles, sexual function, and sexual satisfaction [26]. Although 
these cognitive and behavioral variables are associated with psychosexual functioning in chronic pain 
and PVD samples [23-26], they have never been examined in the two PVD subgroups separately. Given 
the role of these variables in the experience of PVD, their clinical relevance, and the reported biomedical 
differences between the two groups, it is important to assess whether these psychosocial factors would 
also be expressed differently in each PVD subgroup. 
 
The available literature on the sexual and psychosocial functioning of women with PVD1 and PVD2 has 
generated conflicting data. The discrepancies in findings could be explained by the fact that most studies 
have been limited by small, clinical samples and have focused on a limited number of sexual and 
psychosocial variables. It is thus not clear to which extent the reported biomedical differences between 
the two groups are mirrored by or lead to psychosexual differences. Nevertheless, working under the 
assumption that PVD is a complex, multi-factorial chronic pain syndrome, it is of interest to see whether 
both groups differ in terms of psychosexual functioning (1) because patients are as preoccupied about 
their sexual dysfunction, psychological distress and negative impact on their relationship as they are 
about the pain itself, and (2) to offer adequate clinical psychosexual support for both subgroups. 
Therefore, the aim of the present study was to build upon and extend previous studies by comparing 
women with PVD1 and PVD2 on a broader range of sociodemographic, pain, sexual, psychological and 
relational characteristics in a large combined clinical and community sample of premenopausal women 
with provoked vestibulodynia. Based on previous research, we hypothesized that the two subgroups 
would differ on certain sociodemographic, pain and sexuality variables, but that they would present 
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relatively similar psychological profiles. There was not enough research from which to draw from to 
formulate hypotheses concerning the interpersonal variables introduced in this study. 
 
Methods 
Participants 
Participants were recruited through referrals by gynecologists or other health professionals, as well as 
through local newspapers and website advertisements. If women were interested in the study, they 
were screened to determine their eligibility. The inclusion criteria were: 1) pain during intercourse that 
was subjectively distressing, occurred on at least 75% of intercourse attempts, and had lasted > 6 
months; 2) pain limited to intercourse and other activities that caused pressure to be exerted on the 
vulvar vestibule (e.g., riding a bicycle); and (3) severe pain (minimum average pain of 5 on an 11-point 
numerical rating scale) in one or more vestibular locations during the cotton swab test. The exclusion 
criteria were: 1) vulvar pain not clearly linked to intercourse or pressure to the vestibule; 2) presence of 
one of the following: a) major medical and/or psychiatric illness, b) active genital or urinary infection, c) 
deep dyspareunia, d) vaginismus as per DSM-IV criteria, e) dermatologic lesion, f) pregnancy, and g) age 
< 18 years old or > 45 years old. Primary PVD was characterized by women recalling pain from first 
attempts at vaginal penetration (including tampon insertion, sexual activity, etc.). Secondary PVD was 
characterized by vulvo-vaginal pain appearing after a period of pain-free vaginal intercourse. 
 
Procedure 
Women recruited through gynecologists were instructed to meet with the research assistant at the clinic 
to determine their eligibility. Women recruited through referrals by other health care professionals or 
via advertisements were first screened by telephone and given an appointment with one of the 
participating gynecologists. Women were given a questionnaire package that included a consent form, 
investigator-derived standard medical and pain questionnaires as well as validated questionnaires 
assessing women’s psychological, relational and sexual functioning. The study was approved by the 
Institutional Review Board of the University of Montréal. 
 
Main Outcome Measures 
Descriptive variables 
Participants completed questionnaires that gathered information on demographics, medical and 
gynecological histories, relationship and sexual experiences. 
Pain  
Pain intensity was assessed using an 11-point numerical rating scale (NRS) by asking participants to 
estimate their average provoked vulvo-vaginal pain over the past month (0 represented the absence of 
pain and 10 constituted the worst pain ever experienced). This instrument is widely used in chronic pain 
studies [27] and has a good validity and reliability in assessing different types of pain [28]. It correlates 
well with other measures of pain [29]. 
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The McGill-Melzack Pain Questionnaire (MPQ) [30] is both a qualitative and quantitative measure of 
pain which includes 77 adjectives, three scales (sensory, evaluative, and affective) and three indices 
(pain rating index, number of words chosen and present pain index). High scores on this questionnaire 
indicate a more severe pain experience. This questionnaire has an excellent internal validity [30] and 
also very good discriminant validity [31]. It has good test-retest reliability for each measured dimension 
[32].  
 
Sexual Functioning and Satisfaction 
Global sexual functioning was measured by the Female Sexual Function Index (FSFI) [33] for participants 
who had vaginal penetration in the last 4 weeks. The FSFI consists of 19 items focusing on the following 
dimensions of sexual function: desire, arousal, lubrication, orgasm, satisfaction, and pain/discomfort. 
Higher scores indicate better sexual function, and the proposed cutoff for sexual dysfunction is 26,55 
[34]. The FSFI has very good psychometric qualities, is easy to administer, and discriminates clinical from 
non-clinical populations [35]. The Cronbach’s alpha for the present sample was 0.79. 
The Global Measure of Sexual Satisfaction (GMSEX) [36] was used to measure sexual satisfaction. The 
GMSEX is a five-item measure that assesses satisfaction using a seven-point Likert scale. The total score 
ranges from 5 to 35 with higher scores corresponding to a higher sexual satisfaction. The scale has good 
reliability and excellent validity [37]. The Cronbach’s alpha in the present sample was 0.90. 
 
Psychological Factors 
Trait anxiety was assessed with the Trait Anxiety Inventory. The Trait Anxiety Inventory is a 20-item 
subscale of the State-Trait Anxiety Inventory (STAI) [38]. All items are rated on a 4-point Likert scale 
from 1 (not at all) to 4 (very much so). Internal consistency of the Trait subscale is high (0.93) [38] and 
the Trait subscale produces excellent test-retest coefficients (average r=0.88 at a variety of time 
intervals) [39]. The Cronbach’s alpha in the present sample was 0.92.  
Adapted from the Arthritis Self-Efficacy Scale [40], the Painful Intercourse Self-Efficacy Scale is a 20-item 
self-report questionnaire that was used to measure a participant’s perceived ability to participate in 
sexual activity or to reach certain goals in pain management. The questionnaire is divided into the three 
dimensions of self-efficacy associated with pain during intercourse: 1) self-efficacy for controlling pain 
during intercourse; 2) self-efficacy for sexual function; and 3) self-efficacy for controlling other 
symptoms. Participants responded to items on a 10-point scale ranging from 10 (very uncertain), 50 
(moderately uncertain), to 100 (very certain). The original version of the scale was found to have good 
internal consistency among a sample of patients with arthritis (Cronbach alpha ranging from 0.76 to 
0.89) and acceptable test-retest reliability [40]. In this sample, the Cronbach alpha was 0.89. 
Pain Catastrophizing was assessed with the Pain Catastrophizing Scale (PCS) [41]. This PCS consists of 13 
items measuring exaggerated negative thoughts and feelings about the meaning of pain. Each of the 13 
items is rated on a Likert scale from 0 (not at all) to 4 (all the time). The PCS is composed of three 
subscales: rumination, magnification, and helplessness. Higher scores indicate greater catastrophizing 
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and scores can range from 0 to 52. The reliability and validity of the PCS have been well established [41, 
42]. The Cronbach’s alpha in the present sample was 0.87. 
Participants were asked how many times in the past month they had attempted to have sexual 
intercourse with vaginal penetration. The actual number of attempts, successful or not, was taken as the 
behavioral measure of avoidance, with a lower number of attempts being indicative of more avoidance 
[43]. 
Depression was measured via the Beck Depression Inventory-II (BDI-II), comprised of 21 items, with 
scores for most items ranging from 0 (low intensity) to 3 (high intensity) [44, 45]. Greater scores indicate 
greater depressive symptoms, with scores from 0 to 9 indicating minimal symptoms, 10 to 18 indicating 
mild to moderate, and 19 and over indicating moderate to severe. This measure of depression has been 
validated for use in chronic pain populations [46]. The Cronbach’s alpha in the present sample was 0.86. 
Assertiveness in sexual situations was assessed using the 25-item Hurlbert Index of Sexual Assertiveness 
[47]. Agreement with each statement was rated on a 5-point Likert scale ranging from 1 (none of the 
time) to 5 (all of the time). The summation of each item provided a global score of sexual assertiveness 
ranging from 0 to 100, with higher scores representing a better capacity to be assertive with sexual 
partners. Reliability and validity have been well demonstrated [47-49]. The Cronbach’s alpha in the 
present sample was 0.90. 
Ambivalence over emotional expression (AEE) was measured with the Ambivalence over Emotional 
Expression Questionnaire (AEQ) [22]. This self-report measure consists of 28 items, with a total score 
being computed on a five-point scale and higher scores indicating more AEE. The AEQ has been shown 
to have good psychometric properties, including good internal stability (α =0.89), test-retest reliability, 
and convergent validity [22]. The Cronbach’s alpha in the present sample was 0.93. 
 
Relationship Factors 
The revised Dyadic Adjustment Scale (DAS-R) [50] was used to evaluate relationship adjustment 
according to the following dimensions: consensus, satisfaction, cohesion, and affectional expression. 
The DAS-R includes only 14 items, each of which asks the respondents to rate certain aspects of her/his 
relationship on a 5 or 6 point scale. Scores on the DAS-R range from 0 to 69 with higher scores indicating 
greater relationship satisfaction and lower scores indicating greater relationship distress. The cut-off 
score for the DAS-R is 48 such that scores of 48 and above indicate non-distress and scores of 47 and 
below indicate marital/relationship distress. The original DAS shows good psychometric properties, and 
the revised scale is a shorter version that shows high correlation with the original [50]. The Cronbach’s 
alpha in the present study was 0.83. 
The two dimensions of romantic attachment were measured using the Experiences in Close 
Relationships Scale-Revised (ECR-R) [51]. This 36-item scale consists of two 18-item subscales assessing 
anxiety about rejection and avoidance of intimacy. The extent of agreement with each item is rated on a 
Likert scale from 1 (strongly disagree) to 7 (strongly agree). One score for each dimension was computed 
by averaging items of each subscale, with higher scores indicating higher attachment anxiety and 
avoidance. Fraley et al. (2000) have provided evidence for the reliability and validity of the ECR-R [51]. In 
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the current sample, Cronbach’s alphas were 0.88 for the anxiety subscale and 0.86 for the avoidant 
subscale. 
 
Statistical Analyses  
All data were analyzed using SPSS version 21 (IBM Corporation, Armonk, NY, USA). First, independent 
samples t tests (Mann-Whitney U-test) were used to compare the primary and secondary PVD subtypes 
on sociodemographics and pain characteristics. Second, analyses of covariance (ANCOVA) controlling for 
relevant sociodemographics were used to compare the two PVD subgroups on sexual, psychological and 
relationship measures. The BDI-II, Hurlbert Index of Sexual Assertiveness, AEQ and ECR-R were added at 
a later stage of the study and therefore were only completed by part of the sample (n=161), of which 50 
women (31%) had PVD1, and 111 women (39%) had PVD2. The significance level was set at alpha =0.05.  
 
Results 
Sample Characteristics 
The sample comprised 269 participants. One hundred and eight (40%) responded to an advertisement 
and 161 women (60%) were referred by a health care professional, i.e., had been seeking care, and were 
thus considered to be more of a clinical sample. They were all diagnosed with PVD by a gynecologist. 
Ninety-four women (35%) had primary PVD, and 175 (65%) had secondary PVD. As shown in Table 1, the 
mean age of the sample was 27.1 years (range = 19-45, SD=5.6). The mean relationship duration was 
48.0 months (range = 0.5-276, SD=45.4). The majority (85.9%) identified culturally as Canadian and were 
Catholic (79.2%). Participants were found to be well educated, with a mean of 15.9 years of education 
(range = 7-24, SD=2.5), and 47.6% of the women had a household income of > $60.000 per year. All 
women who did not engage in intercourse (21.5%) were asked the reason for not engaging in 
intercourse, and 36% indicated that pain was at least one of the potential reasons. 
The means and standard deviations for each variable based on group (PVD 1 and PVD2) are provided in 
Table 1. Women with PVD1 were significantly younger than women with PVD2 (26.0 ± 5.5 vs 27.7 ± 5.5 
years, respectively, p<.01). The average duration of the present committed relationship was significantly 
longer in women with PVD2 (53.0 ± 46.7 months) compared to women with PVD1 (38.7 ± 41.6 months), 
p<.01. Furthermore, at first sexual intercourse attempt, women with PVD2 (17.4 ± 2.5 years) were 
significantly younger than women with PVD1 (18.2 ± 3.6 years), p<.05. Finally, there were no significant 
subtype differences on education level, annual household income, culture or religion. Because of these 
group differences, duration of committed relationship and age at first sexual intercourse attempt were 
controlled for in subsequent analyses. Age was not controlled for because it correlated significantly with 
the duration of pain symptoms (r=.37) and the duration of committed relationship (r=.51).  
 
Descriptive Statistics 
Pain Characteristics 
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Self-reported pain characteristics of both groups are compared in Table 2.  Women with PVD rated the 
intensity of the vulvo-vaginal pain as very high on average (6.8/10, SD =1.7). However, no significant 
subtype differences were found in mean coital NRS pain score and in total MPQ score. The mean pain 
duration of the total PVD sample was 61.6 months (range = 2.0-303.9, SD=53.6). Women with PVD1 
described a significantly longer duration of pain compared to women with PVD2 (89.8 vs 46.2 months, 
p<.01). Pain duration was thus controlled for in all subsequent analyses. 
 
Sexual Functioning and Satisfaction 
Results concerning sexual functioning and satisfaction of both groups are summarized in Table 3. 
Although the women of both groups presently having sexual intercourse (n=201), on average, were in 
the clinical range of female sexual dysfunction [34], there were no significant differences with respect to 
FSFI total score between women with PVD1 and PVD2. In terms of sexual satisfaction, again, on average, 
no significant differences were found between women with PVD1 and PVD2. 
 
Psychological Factors 
Results of the STAI Trait Anxiety, Painful Intercourse Self-Efficacy Scale, Pain Catastrophizing Scale, Beck 
Depression Inventory-II, Hurlbert Index of Sexual Assertiveness, and Ambivalence over Emotional 
Expression Questionnaire are summarized in Table 3. There were no significant differences between 
women with PVD1 and PVD2 with respect to any of the measures of psychological functioning. For both 
groups, the mean BDI-II score indicated the presence of mild to moderate depressive symptoms. Finally, 
no significant differences were found between both groups in the number of sexual intercourse 
attempts.  
 
Relationship Factors 
As shown in Table 3, no significant differences were found on the Dyadic Adjustment Scale - Revised 
total score between women with primary and secondary PVD. Average dyadic adjustment suggested no 
clinically meaningful relationship distress in both PVD groups. Furthermore, no significant differences 
were found in attachment anxiety and avoidance between women with PVD1 and PVD2.  
 
Discussion 
Previous research has been inconclusive as to whether differences exist in sexual and psychosocial 
functioning between women with PVD1 and PVD2. The aim of the present study was to build upon and 
extend previous studies by comparing women with PVD1 and PVD2 on a broader range of 
sociodemographic, pain, sexual, psychological and relational characteristics in a large combined clinical 
and community sample of premenopausal women with PVD. The present study showed that, when 
controlling for sociodemographics, no significant differences were found in sexual, psychological and 
relational functioning between both PVD subgroups. Nevertheless, on average, both groups were in the 
clinical range of sexual dysfunction and reported impaired psychological functioning. 
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In line with previous research [7, 11, 14], results showed significant differences in age, with women with 
PVD1 being significantly younger than women with PVD2. This is consistent with the fact that they 
experience pain since their first intercourse attempt, whereas women with PVD2 might develop pain 
after a number of years of a satisfying sex life. In contrast with previous research [19], women with 
PVD1 were significantly older at first sexual intercourse attempt compared to women with PVD2. It 
could be assumed that women with PVD1 are less interested in sex or have more conservative sexual 
attitudes. However, when experiencing vulvar pain during tampon use or during first sexual experiences, 
these women may become insecure and less likely to explore further sexual activity, namely sexual 
intercourse. The average duration of the present committed relationship was significantly longer in 
women with PVD2 compared to women with PVD1. This makes sense in light of the difference in age 
between both PVD subgroups. Finally, in line with previous research [6, 14, 18, 19], the current study did 
not show significant subtype differences on education level, annual household income, culture and 
religion. 
Women with PVD1 presented with a significantly longer duration of pain compared to women with 
PVD2. These results corroborate previous findings [19] and are not surprising given the fact that women 
with PVD1 report vulvo-vaginal pain starting from their first attempt of vaginal penetration. In line with 
the findings of previous studies [29, 52], women with PVD rated the intensity of the vulvo-vaginal pain 
as very high on average. However, in the current study, no significant subtype differences were found in 
mean coital NRS pain score and in total MPQ score. These results corroborate findings of two previous 
studies comparing pain characteristics between the two subtypes of PVD [5, 18], but are in contrast with 
the results of a recent clinical-based study showing that women with PVD2 rated their pain symptoms 
significantly more severely than women with PVD1 [19]. These discrepant findings might be the result of 
different types of samples (clinical versus community). 
Using the FSFI, Brotto et al. (2014) showed that women with PVD2 reported significantly worse sexual 
functioning than women with PVD1 [19]. Sutton et al. (2009) on the other hand, did not find any 
differences in sexual response between both PVD subgroups [18]. The results of the current study are in 
line with the latter findings, showing that women with PVD1 and PVD2 did not differ with respect to 
sexual functioning and sexual satisfaction. Although both the current study and the study of Brotto et al. 
(2014) are based on fairly large sample sizes (269 and 132 women with PVD, respectively), women 
participating in the study of Brotto et al. (2014) were all actively seeking treatment for their PVD 
symptoms, whereas the current study was based on a combined clinical and community sample, where 
participants may have been less distressed on average. Further, in the present study, duration of pain 
symptoms, age at first sexual intercourse attempt and duration of the current partner relationship were 
controlled for because (1) they were different between the two groups yet are unrelated to etiology and 
(2) are either associated with sexual function and/or chronic pain outcomes [53, 54] .  
In contrast to previous studies examining both subtypes of PVD [6, 18, 21], the current sample showed 
that women with PVD1 and PVD2 did not differ significantly on depression, trait anxiety, pain self-
efficacy, catastrophizing and dyadic adjustment. These results are in line with findings from a recent 
large scale study [19]. In addition, the present study also showed that no significant difference existed 
between women with PVD1 and PVD2 in terms of behavioral avoidance of vaginal penetration, sexual 
assertiveness, ambivalence over emotional expression and romantic attachment – more interpersonal 
psychological variables. This suggests that although women with PVD1 and PVD2 may differ in terms of 
their biomedical characteristics, and possibly, etiology, they nevertheless present similar psychosocial 
profiles.  
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Taken together, findings of the present study suggest that, when controlling for sociodemographics, 
there are no significant differences in the sexual and psychosocial profiles of women with primary and 
secondary PVD. Nevertheless, on average, both groups were functioning below the clinical cut-off (26.5) 
for female sexual dysfunction [34]. Moreover, although there were no subtype differences, 
psychological impairments were also common in both groups.  
The present study expanded upon the investigation of sexual and psychosocial factors in these PVD 
subgroups by using a large, combined clinical and community sample of women with PVD, and by 
including a wide range of intra-individual and interpersonal psychosocial factors. As a result, the findings 
of the present study may be more representative of the general population of women afflicted with 
provoked vestibulodynia. Finally, analyses concerning sexual and psychosocial functioning between the 
two subgroups were performed after controlling for relevant sociodemographics, which are distinct 
from etiology. In addition to the strengths of the present study, there are limitations that must be 
considered. First, we only assessed women with a premenopausal status. Thus, our findings may not be 
generalizable to the PVD population as a whole. By limiting recruitment only to premenopausal women 
younger than 45, we excluded the possibility of examining potential subtype differences that may be 
due to estrogen deficiency. Second, certain factors that have been shown to be associated with the 
development of PVD, such as pain during tampon insertion and avoidance of tampon use before 
first sexual intercourse [55], lifetime occurrence of sexual abuse [55], lifetime frequency of fearing 
physical abuse [55] and the use of combined hormonal contraceptives [56-60], were not assessed in 
the present study and could have influenced our results. Finally, all the measures consisted of self-report 
questionnaires, which are subject to social desirability biases.  
Since the present study showed group differences in socio-demographic variables, such as age, duration 
of pain, duration of the present committed relationship and age at first intercourse attempt, future 
studies comparing etiology, biomedical and psychosexual treatment between women with primary and 
secondary PVD, should control for sociodemographics in their analyses. Furthermore, more research is 
needed concerning potential differences in treatment response between women with PVD1 and 
PVD2, including psychosexual interventions and using RCT methodologies. Such findings could 
further orient our treatment recommendations.  
In term of clinical implications, findings suggest that similar psychosocial and sex therapy interventions 
should be offered to both subgroups of PVD. Indeed, although several authors have suggested that 
PVD1 and PVD2 are two different entities in terms of etiological pathways [6-14] and treatment 
response [5, 15, 16, 20], the current study indicates that vulvar pain is associated with impairments in 
sexual functioning and psychosocial well-being in both PVD subgroups. Therefore, clinicians should be 
sensitive to the sexual and psychosocial needs of women with PVD, regardless of subtype, through 
provision of accurate education and psychosexual support.  
 
Conclusion 
Including a wide range of intra-individual and interpersonal psychosocial factors, the findings of the 
present study suggest that women with PVD1 and PVD2 do not differ with respect to sexual and 
psychosocial profiles. However, both groups experience significant degrees of sexual dysfunction and 
psychological impairment. Our results support the integration of psychosocial and sex therapy 
interventions in the treatment of both subgroups of PVD.  
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Table 1: Sociodemographic characteristics  
 Total Sample 
N=269 
PVD1 
n=94 
PVD2 
n=175 
Age (years) **  
Years of schooling                                
Duration present committed relationship (months) ** 
Age first sexual intercourse** 
Culture (%)   
   Canadian 
   American 
   European 
   African 
   Asian 
   Middle Eastern 
   South American or Caribbean 
   Other 
Religion (%)    
   Catholic 
   Protestant 
   Jewish 
   Other 
   Non 
   Not specified 
Annual household income (%)  
   Less than $60.000 
   More than $ 60.000 
27.1 ± 5.6  
15.9 ± 2.5  
48.0 ± 45.4  
17.5 ± 2.9  
 
90.0 
0.7 
4.1 
1.1 
0.4 
0.4 
2.6 
0.7 
 
79.3 
2.2 
1.1 
3.3 
12.6 
1.5 
 
52.4 
47.6 
26.0 ± 5.5  
15.7 ± 2.5  
38.7 ± 41.6  
18.2 ± 3.6  
 
87.2 
0 
6.4 
2.1 
1.1 
1.1 
2.1 
0 
 
75.5 
4.3 
1.1 
3.2 
13.8 
2.1 
 
60.6 
39.4 
27.7 ± 5.5  
16.0 ± 2.4 
53.0 ± 46.7  
17.1 ± 2.5  
 
91.4 
1.1 
2.9 
0.6 
0 
0 
2.9 
1.1 
 
81.1 
1.1 
1.1 
3.4 
12.2 
1.1 
 
48.0 
52.0 
 
PVD1= Primary Provoked Vestibulodynia; PVD2= Secondary Provoked Vestibulodynia 
Values are % or means ± standard deviation 
Significant differences between PVD1 and PVD2: * P < 0.05; **P < 0.01 
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Table 2: Characteristics of Self-Reported Pain  
 
 Total Sample 
N=269 
PVD1 
n=94 
PVD2 
n=175 
Duration pain experience (months) ** 
Pain intensity (0-10) 
MPQ Total 
61.6 ± 53.6 
6.8 ± 1.7 
31.8 ± 14.4 
 89.8 ± 64.9 
6.7 ± 1.6 
32.8 ± 13.5 
 46.2 ± 38.7 
6.8  ± 1.8 
31.2 ± 14.9 
 
PVD1= Primary Provoked Vestibulodynia; PVD2= Secondary Provoked Vestibulodynia 
MPQ= McGill-Melzack Pain Questionnaire 
Values are means ± standard deviation 
Significant differences between PVD1 and PVD2: * P < 0.05; **P < 0.01 
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Table 3: Sexual, psychological and relationship characteristics  
 Total Sample 
N=269 
PVD1 
n=94 
PVD2 
n=175 
FSFI Total 
GMSEX 
 
STAI Trait 
Painful Intercourse Self-Efficacy Total score 
PCS Total score 
Intercourse attempts in past month 
BDI-II 
Hurlbert Index of Sexual Assertiveness 
AEQ 
 
RDAS Total score 
ECR-R Anxiety 
ECR-R Avoidance 
 
19.7 ± 6.6 
23.8 ± 6.0 
 
42.9 ± 10.9 
62.7 ± 14.4 
27.0 ± 10.4 
4.4 ± 4.5 
11.0 ± 8.0 
37.8 ± 15.1 
 2.5 ± 0.7 
 
51.0 ± 7.2 
44.3 ± 17.3 
43.1 ± 14.2 
 
20.1 ± 6.2  
23.2 ± 6.1 
 
44.0 ± 10.9 
63.8 ± 13.9 
27.6 ± 10.0 
5.1 ± 4.8 
10.6 ± 7.8 
41.4 ± 14.2 
2.6 ± 0.7 
 
50.9 ± 7.3 
46.8 ± 18.9 
41.2 ± 11.3 
 
19.5 ± 6.8  
24.1 ± 6.0 
 
42.3 ± 10.9 
62.0 ± 14.7 
26.7 ± 10.7 
4.1 ± 4.3  
11.2 ± 8.2 
36.2 ± 15.3 
2.4 ± 0.7 
 
51.0 ± 7.1 
43.1 ± 16.6 
44.0 ± 15.3 
 
 
PVD1= Primary Provoked Vestibulodynia; PVD2= Secondary Provoked Vestibulodynia 
FSFI = Female Sexual Function Index; GMSEX = Global Measure of Sexual Satisfaction; STAI Trait = Trait 
Anxiety Inventory; PCS = Pain Catastrophizing Scale; BDI-II = Beck Depression Inventory-II; AEQ = 
Ambivalence over Emotional Expression Questionnaire; ECR = Experiences in Close Relationships Scale-
Revised; RDAS = Dyadic Adjustment Scale – Revised 
Values are means ± standard deviation. 
Significant differences between PVD1 and PVD2: * P < 0.05; **P < 0.01 
 
 
 
 
